Dopamine has no direct causal role in the formation of treatment expectations and placebo analgesia in humans
PLOS Biology · 2024
DOI: 10.1371/journal.pbio.3002772 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift PLOS Biology, 2024. Verfasst von Angelika Kunkel und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Medicine Essen, University Duisburg-Essen, Esse…. Hauptthemen laut MEDLINE: Dopamine, Placebo Effect, Analgesia, Levodopa. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), Medizinische Fakultät, Universität Duisburg-Essen.
Abstract (Originalsprache)
Dopamine-based reward and learning mechanisms have been suggested to contribute to placebo effects. However, the exact role of dopaminergic neurotransmission in their generation and maintenance is still unclear. This study aimed to shed light on the causal role of dopamine in establishing positive treatment expectations, as well as on the magnitude and duration of their effect on pain. To this end, we used an established placebo analgesia paradigm in combination with 2 opposing pharmacological modulations of dopaminergic tone, i.e., the dopamine antagonist sulpiride and the dopamine precursor L-dopa which were both applied in an experimental, double-blind, randomized, placebo-controlled trial with a between-subject design in N = 168 healthy volunteers. The study medication successfully altered dopaminergic tone during the conditioning procedure. Contrary to our hypotheses, the medication did not modulate the formation of positive treatment expectation and placebo analgesia tested 1 day later. Placebo analgesia was no longer detectable on day 8 after conditioning. Using a combined frequentist and Bayesian approach, our data provide strong evidence against a direct dopaminergic influence on the generation and maintenance of placebo effects. Further exploration of the neurochemical mechanisms underlying placebo analgesia remains paramount in the quest to exploit these effects for optimal treatment outcomes. Trial registration : ClinicalTrials.gov German Clinical Trials Register, ID: DRKS00029366 , https://drks.de/search/en/trial/DRKS00029366 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Medicine Essen, University Duisburg-Essen, Essen, Germany.
- Wellcome Centre for Integrative Functional Neuroimaging, Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.
ORCID-Profile: Angelika Kunkel, Ulrike Bingel
Förderung
- Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)
- Medizinische Fakultät, Universität Duisburg-Essen
Zitieren
APA
Kunkel, A., Asan, L., Krüger, I., Erfurt, C., Ruhnau, L., Caliskan, E. B., Hackert, J., Wiech, K., Schmidt, K., & Bingel, U. (2024). Dopamine has no direct causal role in the formation of treatment expectations and placebo analgesia in humans. PLOS Biology. https://doi.org/10.1371/journal.pbio.3002772
Vancouver
Kunkel A, Asan L, Krüger I, Erfurt C, Ruhnau L, Caliskan EB, et al. Dopamine has no direct causal role in the formation of treatment expectations and placebo analgesia in humans. PLOS Biology. 2024. doi:10.1371/journal.pbio.3002772
BibTeX
@article{Kunkel2024,
author = {Kunkel, Angelika and Asan, Livia and Krüger, Isabel and Erfurt, Clara and Ruhnau, Laura and Caliskan, Elif Buse and Hackert, Jana and Wiech, Katja and Schmidt, Katharina and Bingel, Ulrike},
title = {Dopamine has no direct causal role in the formation of treatment expectations and placebo analgesia in humans},
journal = {PLOS Biology},
year = {2024},
doi = {10.1371/journal.pbio.3002772}
}
EUVIMED